Pandey M S, Belgamwar V S, Surana S J
Department of Pharmaceutics, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur-425 405, India.
Indian J Pharm Sci. 2009 Jan;71(1):87-90. doi: 10.4103/0250-474X.51955.
The purpose of this research is to formulate and evaluate the suitability of pluronic lecithin organogels containing flurbiprofen for topical application. Four formulations were developed using flurbiprofen, lecithin, Pluronic F127, isopropyl palmitate, water, sorbic acid and potassium sorbate were coded as FL1, FL2, FL3 and FL4. All the formulations carried 30% w/w of lecithin phase and 70% w/w of Pluronic phase. The formulated organogels were evaluated for appearance and feel psychorheologically, in vitro diffusion study, drug content, viscosity and pH. Release of flurbiprofen from all formulations was monitored via dialysis membrane-70 and Wistar rat skin as a semipermeable membrane into phosphate buffer saline (0.2 M, pH 7.4) using Keshary-Chien diffusion cell. The viscosities of different formulations were determined by using Brookfield Viscometer at 25 degrees . An attempt has been made to explore the potential of pluronic lecithin organogels for topical delivery of flurbiprofen.
本研究的目的是制备并评估含氟比洛芬的普朗尼克卵磷脂有机凝胶用于局部给药的适用性。使用氟比洛芬、卵磷脂、普朗尼克F127、棕榈酸异丙酯、水、山梨酸和山梨酸钾开发了四种制剂,分别编码为FL1、FL2、FL3和FL4。所有制剂均含有30% w/w的卵磷脂相和70% w/w的普朗尼克相。对所制备的有机凝胶进行外观、触感、流变学、体外扩散研究、药物含量、粘度和pH值评估。使用Keshary-Chien扩散池,通过透析膜-70和作为半透膜的Wistar大鼠皮肤,监测所有制剂中氟比洛芬向磷酸盐缓冲盐水(0.2 M,pH 7.4)的释放情况。使用Brookfield粘度计在25℃下测定不同制剂的粘度。已尝试探索普朗尼克卵磷脂有机凝胶用于氟比洛芬局部给药的潜力。